Skip to main content
. 2020 Dec 15;21(2):115. doi: 10.3892/ol.2020.12376

Figure 3.

Figure 3.

Antitumor activity measured using an MTT assay in (A) 3T3, (B) B16, (C) H460, (D) HepA1-6, (E) HepG2, (F) huh7 and (G) MCF7cell lines after treatment with anti-tumor peptides and their RGD chimeras. T-La, Temporin-La; (FS), antitumor.